Impact of CYP3A4 Genotype on Voriconazole Exposure

Clin Pharmacol Ther. 2018 Feb;103(2):185-186. doi: 10.1002/cpt.809. Epub 2017 Aug 29.

Authors

Thomas Duflot^{1

2}, Aurélien Schrapp¹, Jérémy Bellien^{1

2}, Fabien Lamoureux^{1

2}

Affiliations

¹ Rouen University Hospital, Department of Pharmacology - Toxicology and Pharmacogenetics, Rouen, France.
² Normandie University, UNIROUEN, Inserm U1096, Rouen, France.

PMID: 28786228
DOI: 10.1002/cpt.809

No abstract available

Publication types

Letter
Comment

MeSH terms

Antifungal Agents*
Cytochrome P-450 CYP2C19 / genetics
Cytochrome P-450 CYP3A / genetics
Genotype
Pharmacogenetics*
Voriconazole

Substances

Antifungal Agents
Cytochrome P-450 CYP2C19
Cytochrome P-450 CYP3A
Voriconazole